GC
ALAB icon

Gratus Capital’s Astera Labs ALAB Stock Holding History

Gratus Capital’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$4.52M Buy
+74,781
New +$5.19M 0.18% 101

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

Gratus Capital's ALAB Position: Q2 2024 in Review

Gratus Capital opened a new position in Astera Labs (ALAB) in Q2 2024: 74,781 shares worth $4.52M. The stake represents 0.18% of the portfolio and ranks #101 among its holdings.

146 funds tracked by Wall St. Rank hold ALAB as of Q2 2024.

  • Gratus Capital held 74,781 shares of Astera Labs worth $4.52M as of Q2 2024.
  • Astera Labs was a new Gratus Capital position in Q2 2024.
  • Astera Labs made up 0.18% of Gratus Capital's portfolio in Q2 2024, its #101 holding.
  • 146 funds tracked by Wall St. Rank held Astera Labs as of Q2 2024.

Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.